These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25214510)

  • 1. Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
    Sospedra M; Schippling S; Yousef S; Jelcic I; Bofill-Mas S; Planas R; Stellmann JP; Demina V; Cinque P; Garcea R; Croughs T; Girones R; Martin R
    Clin Infect Dis; 2014 Dec; 59(11):1588-92. PubMed ID: 25214510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
    Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
    MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study.
    Cortese I; Beck ES; Al-Louzi O; Ohayon J; Andrada F; Osuorah I; Dwyer J; Billioux BJ; Dargah-Zada N; Schindler MK; Binder K; Reoma L; Norato G; Enose-Akahata Y; Smith BR; Monaco MC; Major EO; Jacobson S; Stroncek D; Highfill S; Panch S; Reich DS; Barrett J; Nath A; Muranski P
    Lancet Neurol; 2021 Aug; 20(8):639-652. PubMed ID: 34302788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy.
    Jochum W; Weber T; Frye S; Hunsmann G; Lüke W; Aguzzi A
    Acta Neuropathol; 1997 Sep; 94(3):226-31. PubMed ID: 9292691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
    Harypursat V; Zhou Y; Tang S; Chen Y
    AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsid protein VP1 deletions in JC virus from two AIDS patients with progressive multifocal leukoencephalopathy.
    Stoner GL; Ryschkewitsch CF
    J Neurovirol; 1995 Jun; 1(2):189-94. PubMed ID: 9222357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy.
    Aoki N; Mori M; Kato K; Sakamoto Y; Noda K; Tajima M; Shimada H
    Neurosci Lett; 1996 Feb; 205(2):111-4. PubMed ID: 8907329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain.
    Okada Y; Sawa H; Endo S; Orba Y; Umemura T; Nishihara H; Stan AC; Tanaka S; Takahashi H; Nagashima K
    Acta Neuropathol; 2002 Aug; 104(2):130-6. PubMed ID: 12111355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.
    Gorelik L; Reid C; Testa M; Brickelmaier M; Bossolasco S; Pazzi A; Bestetti A; Carmillo P; Wilson E; McAuliffe M; Tonkin C; Carulli JP; Lugovskoy A; Lazzarin A; Sunyaev S; Simon K; Cinque P
    J Infect Dis; 2011 Jul; 204(1):103-14. PubMed ID: 21628664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
    Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
    J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?
    Jelcic I; Combaluzier B; Jelcic I; Sospedra M; Grimm J; Martin R
    Swiss Med Wkly; 2017; 147():w14520. PubMed ID: 29120025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia.
    Patel A; Patel J; Ikwuagwu J
    J Antimicrob Chemother; 2010 Dec; 65(12):2697-8. PubMed ID: 20864499
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa.
    Glass AJ; Venter M
    J Med Virol; 2009 Nov; 81(11):1929-37. PubMed ID: 19774679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?
    Lauver MD; Lukacher AE
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33053912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies.
    Goldmann C; Petry H; Frye S; Ast O; Ebitsch S; Jentsch KD; Kaup FJ; Weber F; Trebst C; Nisslein T; Hunsmann G; Weber T; Lüke W
    J Virol; 1999 May; 73(5):4465-9. PubMed ID: 10196348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.
    Ferrante P; Mediati M; Caldarelli-Stefano R; Losciale L; Mancuso R; Cagni AE; Maserati R
    J Neurovirol; 2001 Feb; 7(1):35-42. PubMed ID: 11519480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
    Khalili A; Craigie M; Donadoni M; Sariyer IK
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
    Koralnik IJ; Du Pasquier RA; Letvin NL
    J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress on pathogenesis of progressive multifocal leukoence-phalopathy].
    Hu C; Zhu B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):534-540. PubMed ID: 30693697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.